Felty's syndrome (FS) is a rare association of rheumatoid arthritis (RA), neutropenia and splenomegaly. Mechanisms of neutropenia in FS are unclear but involve both innate and humoral immunity, impaired granulopoiesis and decreased granulocyte half-life. Several treatments have been used without clear efficiency. We report a patient with FS efficiently treated with rituximab (RTX), the monoclonal anti-CD20 antibody. A literature review of FS treated with RTX was performed. (C) 2012 Published by Elsevier Masson SAS on behalf of the Societe Francaise de Rhumatologie.
机构:
Nanchang Univ, Affiliated Hosp 2, Dept Rheumatol, Nanchang, Peoples R ChinaNanchang Univ, Affiliated Hosp 2, Dept Rheumatol, Nanchang, Peoples R China
Huang, Tianlun
Liu, Mengyuan
论文数: 0引用数: 0
h-index: 0
机构:
Nanchang Univ, Affiliated Hosp 2, Dept Rheumatol, Nanchang, Peoples R China
Nanchang Univ, Grad Sch, Med Ctr, Nanchang, Peoples R ChinaNanchang Univ, Affiliated Hosp 2, Dept Rheumatol, Nanchang, Peoples R China
Liu, Mengyuan
Xu, Gaosi
论文数: 0引用数: 0
h-index: 0
机构:
Nanchang Univ, Affiliated Hosp 2, Dept Rheumatol, Nanchang, Peoples R ChinaNanchang Univ, Affiliated Hosp 2, Dept Rheumatol, Nanchang, Peoples R China